Articles related to Family Medicine/General Practice

Women presenting with acute myocardial infarction often report chest pain alongside additional symptoms such as dyspnea, nausea, fatigue, or jaw pain. Persistent diagnostic disparities continue to contribute to delays in recognition and treatment, particularly among younger women.

The 2026 ACC/AHA dyslipidemia guideline reintroduces LDL-C treatment targets, expands risk assessment, and recommends universal Lp(a) screening. New analyses suggest many US adults now exceed recommended cholesterol thresholds, although treatment decisions remain individualized.

A post-thyroidectomy patient’s LDL-C rose above 250 mg/dL during recurrent hypothyroidism and improved after euthyroidism returned. The case highlights medication adherence and secondary-cause review before lipid-therapy escalation.

The FDA approved centanafadine for ADHD in adults and children aged 6 years and older, introducing the first approved norepinephrine, dopamine, serotonin reuptake inhibitor for the disorder. Approval was based on phase 3 trial results and regulatory review.

More than 4,100 laboratory-confirmed cyclospora infections have been reported across 41 states during a larger-than-usual US outbreak. Investigators continue to search for the source, and no food product has been definitively confirmed as responsible.

The Department of Defense announced annual testosterone-deficiency screening for service members aged 30 years and older, with optional testing for younger personnel. Clinicians have questioned whether broad population screening aligns with established diagnostic recommendations for hypogonadism.